Table 2.

Adjusted Relative Rate Ratios of Adherence With Fecal Occult Blood Testing and Colorectal Cancer Tests Without FOBT by Patient Characteristics (N=11,110)

OutcomeRRRa (95% CI)
CRC=colorectal cancer; FOBT=fecal occult blood test; ref=reference category; PHE = preventive health examination; RRR = relative rate ratio.
a Relative rate ratio of CRC screening outcome compared with no CRC screening associated with change in covariate value.
b P for linear trend <.001.
Adherent with FOBT vs no screening
Age, year1.02 (1.021.03)
Male sex1.44 (1.311.58)
Charlson Comorbidity Index1.0 (ref)b
    00.78 (0.68–0.88)
    10.93 (0.76–1.13)
    20.53 (0.40–0.69)
    ≥3
No. of primary care visits (2002–2003)1.01 (1.00–1.02)
No. of non–primary care visits (2002–2003)1.00 (0.99–1.01)
Preventive health examination (PHE) during observation period (2002–2003)11.16 (9.61–12.96)
Adherent with CRC tests other than FOBT vs no screening
Age, year0.98 (0.97–0.99)
Male sex1.03 (0.88–1.21)
Charlson Comorbidity Index1.0 (ref)b
    00.80 (0.65–1.00)
    10.68 (0.50–0.92)
    20.63 (0.42–0.96)
    ≥3
No. of primary care visits (2002–2003)1.01 (1.00–1.02)
No. of non–primary care visits (2002–2003)1.02 (1.01–1.03)
PHE during observation period (2002–2003)2.36 (2.02–2.75)